Every record from Janoshik · page 50
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020650 | Semaglutide | SSA | SSA-2412-Y7639 | 2025-Q2 | 97.91 | 4.04 | 105.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018931 | Exenatide | FGP | FGP-2504-V9993 | 2025-Q2 | 98.37 | 3.47 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019647 | Semaglutide | Homopeptide | HOMO-2502-U2648 | 2025-Q2 | 99.37 | 5.11 | 97.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019065 | Liraglutide | JEEP | JEEP-2411-B3841 | 2025-Q2 | 98.83 | 4.94 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020169 | NAD+ | GGPeps | GGPE-2502-W9548 | 2025-Q2 | 98.23 | 12.36 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-019450 | Tirzepatide | Homopeptide | HOMO-2502-U9233 | 2025-Q2 | 98.84 | 6.17 | 104.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018930 | Exenatide | FGP | FGP-2504-V9993 | 2025-Q2 | 98.73 | 3.85 | 98.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021016 | 5-Amino-1MQ | WXT | WXT-2505-M3910 | 2025-Q2 | 98.43 | 2.83 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020858 | Selank | CPC | CPC-2504-F1880 | 2025-Q2 | 98.35 | 9.48 | 97.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-020212 | BPC-157 | GGPeps | GGPE-2411-V1398 | 2025-Q2 | 98.97 | 3.08 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019976 | BPC-157 | SWB | SWB-2504-M6687 | 2025-Q2 | 99.65 | 4.83 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019530 | Semaglutide | Homopeptide | HOMO-2501-A1307 | 2025-Q2 | 99.93 | 5.89 | 93.4 | Supplier-supplied | 0 | PASS |
| AX-2025-018893 | MK-677 (Ibutamoren mesylate) | FGP | FGP-2502-F9841 | 2025-Q2 | 99.47 | 3.71 | 91.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-018552 | TB-500 | WWB | WWB-2501-Y4287 | 2025-Q2 | 99.93 | 2.99 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020392 | AOD-9604 | MKM | MKM-2505-M4185 | 2025-Q2 | 98.59 | 6.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019844 | N-Acetyl Semax Amide | SWB | SWB-2504-W4423 | 2025-Q2 | 99.06 | 9.52 | 91.3 | Supplier-supplied | 0 | PASS |
| AX-2025-019535 | Semaglutide | Homopeptide | HOMO-2501-A1307 | 2025-Q2 | 99.93 | 5.41 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018975 | KPV | FGP | FGP-2501-A1918 | 2025-Q2 | 99.93 | 2.85 | 101.9 | Supplier-supplied | 0 | FAIL |
| AX-2025-020981 | TB-500 | CPC | CPC-2502-V2965 | 2025-Q2 | 99.15 | 4.77 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020219 | Tirzepatide | GGPeps | GGPE-2412-M1040 | 2025-Q2 | 97.93 | 3.79 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019865 | Ipamorelin | SWB | SWB-2501-Y4965 | 2025-Q2 | 99.93 | 5.10 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019767 | Semaglutide | HJ | HJ-2504-Y4203 | 2025-Q2 | 98.11 | 4.87 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021038 | Survodutide | WXT | WXT-2501-X3943 | 2025-Q2 | 97.67 | 4.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020221 | Tirzepatide | GGPeps | GGPE-2412-M1040 | 2025-Q2 | 97.98 | 4.35 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021083 | Tirzepatide | WXT | WXT-2411-F4668 | 2025-Q2 | 98.60 | 4.85 | 98.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020368 | KPV | MKM | MKM-2504-N3869 | 2025-Q2 | 99.74 | 5.47 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-019482 | GHRP-6 | Homopeptide | HOMO-2504-G9629 | 2025-Q2 | 99.89 | 3.60 | 102.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-019155 | CJC-1295 (no DAC) | TFC | TFC-2411-M5192 | 2025-Q2 | 98.76 | 2.43 | 89.0 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-018784 | TB-500 | QSC | QSC-2504-T7980 | 2025-Q2 | 99.61 | 3.57 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018523 | L-Glutathione (reduced) | WWB | WWB-2501-L3929 | 2025-Q2 | 99.86 | 8.72 | 89.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019333 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2505-N7258 | 2025-Q2 | 99.41 | 5.80 | 103.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-019159 | CJC-1295 (no DAC) | TFC | TFC-2411-M5192 | 2025-Q2 | 99.18 | 2.51 | 106.1 | Supplier-supplied | 0 | PASS |
| AX-2025-019332 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2505-N7258 | 2025-Q2 | 99.10 | 5.34 | 96.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-021092 | ARA-290 | WXT | WXT-2502-N5210 | 2025-Q2 | 98.63 | 4.11 | 92.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020713 | BPC-157 | GL Biochem | GLBI-2411-N8871 | 2025-Q2 | 98.41 | 7.91 | 89.0 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-018955 | Tirzepatide | FGP | FGP-2412-N1589 | 2025-Q2 | 98.53 | 4.51 | 106.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019614 | BPC-157 | Homopeptide | HOMO-2505-F2001 | 2025-Q2 | 99.82 | 4.66 | 101.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018550 | TB-500 | WWB | WWB-2501-Y4287 | 2025-Q2 | 99.79 | 3.17 | 102.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020976 | MK-677 (Ibutamoren mesylate) | CPC | CPC-2503-G3418 | 2025-Q2 | 98.16 | 5.57 | 91.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-020851 | Selank | CPC | CPC-2504-F1880 | 2025-Q2 | 98.64 | 9.03 | 98.2 | Supplier-supplied | 0 | FAIL |